id	sid	tid	token	lemma	pos
cord-030594-xhp8kin0	1	1	key	key	JJ
cord-030594-xhp8kin0	2	1	:	:	:
cord-030594-xhp8kin0	2	2	cord-030594-xhp8kin0	cord-030594-xhp8kin0	NNS
cord-030594-xhp8kin0	2	3	authors	author	NNS
cord-030594-xhp8kin0	2	4	:	:	:
cord-030594-xhp8kin0	3	1	nan	nan	NNP
cord-030594-xhp8kin0	3	2	title	title	NN
cord-030594-xhp8kin0	3	3	:	:	:
cord-030594-xhp8kin0	4	1	Dear	dear	JJ
cord-030594-xhp8kin0	4	2	the	the	DT
cord-030594-xhp8kin0	4	3	Editor	editor	NN
cord-030594-xhp8kin0	4	4	,	,	,
cord-030594-xhp8kin0	4	5	date	date	NN
cord-030594-xhp8kin0	4	6	:	:	:
cord-030594-xhp8kin0	4	7	2020	2020	CD
cord-030594-xhp8kin0	4	8	-	-	HYPH
cord-030594-xhp8kin0	4	9	08	08	CD
cord-030594-xhp8kin0	4	10	-	-	SYM
cord-030594-xhp8kin0	4	11	19	19	CD
cord-030594-xhp8kin0	4	12	journal	journal	NN
cord-030594-xhp8kin0	4	13	:	:	:
cord-030594-xhp8kin0	5	1	J	J	NNP
cord-030594-xhp8kin0	5	2	Infect	infect	VB
cord-030594-xhp8kin0	5	3	DOI	DOI	NNP
cord-030594-xhp8kin0	5	4	:	:	:
cord-030594-xhp8kin0	6	1	10.1016	10.1016	CD
cord-030594-xhp8kin0	6	2	/	/	SYM
cord-030594-xhp8kin0	6	3	j.jinf.2020.08.021	j.jinf.2020.08.021	CD
cord-030594-xhp8kin0	7	1	sha	sha	NNP
cord-030594-xhp8kin0	7	2	:	:	:
cord-030594-xhp8kin0	8	1	f797b2075c84a88e9f853f2615955172a9aff916	f797b2075c84a88e9f853f2615955172a9aff916	NNP
cord-030594-xhp8kin0	8	2	doc_id	doc_id	NNP
cord-030594-xhp8kin0	8	3	:	:	:
cord-030594-xhp8kin0	8	4	30594	30594	CD
cord-030594-xhp8kin0	8	5	cord_uid	cord_uid	FW
cord-030594-xhp8kin0	8	6	:	:	:
cord-030594-xhp8kin0	9	1	xhp8kin0	xhp8kin0	NNP
cord-030594-xhp8kin0	9	2	nan	nan	NNP
cord-030594-xhp8kin0	9	3	Kunutsor	Kunutsor	NNP
cord-030594-xhp8kin0	9	4	SK	SK	NNP
cord-030594-xhp8kin0	9	5	et	et	NNP
cord-030594-xhp8kin0	9	6	al	al	NNP
cord-030594-xhp8kin0	9	7	.	.	NNP
cord-030594-xhp8kin0	9	8	have	have	VBP
cord-030594-xhp8kin0	9	9	written	write	VBN
cord-030594-xhp8kin0	9	10	to	to	IN
cord-030594-xhp8kin0	9	11	this	this	DT
cord-030594-xhp8kin0	9	12	journal	journal	NN
cord-030594-xhp8kin0	9	13	regarding	regard	VBG
cord-030594-xhp8kin0	9	14	elevated	elevated	JJ
cord-030594-xhp8kin0	9	15	admission	admission	NN
cord-030594-xhp8kin0	9	16	levels	level	NNS
cord-030594-xhp8kin0	9	17	of	of	IN
cord-030594-xhp8kin0	9	18	markers	marker	NNS
cord-030594-xhp8kin0	9	19	of	of	IN
cord-030594-xhp8kin0	9	20	liver	liver	NN
cord-030594-xhp8kin0	9	21	injury	injury	NN
cord-030594-xhp8kin0	9	22	(	(	-LRB-
cord-030594-xhp8kin0	9	23	alanine	alanine	JJ
cord-030594-xhp8kin0	9	24	aminotransferase	aminotransferase	NN
cord-030594-xhp8kin0	9	25	and	and	CC
cord-030594-xhp8kin0	9	26	aspartate	aspartate	NN
cord-030594-xhp8kin0	9	27	aminotransferase	aminotransferase	NN
cord-030594-xhp8kin0	9	28	,	,	,
cord-030594-xhp8kin0	9	29	gamma	gamma	NN
cord-030594-xhp8kin0	9	30	-	-	HYPH
cord-030594-xhp8kin0	9	31	glutamyltransferase	glutamyltransferase	JJ
cord-030594-xhp8kin0	9	32	,	,	,
cord-030594-xhp8kin0	9	33	alkaline	alkaline	JJ
cord-030594-xhp8kin0	9	34	phosphatase	phosphatase	NN
cord-030594-xhp8kin0	9	35	and	and	CC
cord-030594-xhp8kin0	9	36	total	total	JJ
cord-030594-xhp8kin0	9	37	bilirubin	bilirubin	NN
cord-030594-xhp8kin0	9	38	)	)	-RRB-
cord-030594-xhp8kin0	9	39	may	may	MD
cord-030594-xhp8kin0	9	40	be	be	VB
cord-030594-xhp8kin0	9	41	associated	associate	VBN
cord-030594-xhp8kin0	9	42	with	with	IN
cord-030594-xhp8kin0	9	43	progression	progression	NN
cord-030594-xhp8kin0	9	44	to	to	IN
cord-030594-xhp8kin0	9	45	severe	severe	JJ
cord-030594-xhp8kin0	9	46	disease	disease	NN
cord-030594-xhp8kin0	9	47	or	or	CC
cord-030594-xhp8kin0	9	48	death	death	NN
cord-030594-xhp8kin0	9	49	in	in	IN
cord-030594-xhp8kin0	9	50	COVID-19	COVID-19	NNP
cord-030594-xhp8kin0	9	51	.	.	.
cord-030594-xhp8kin0	10	1	[	[	-LRB-
cord-030594-xhp8kin0	10	2	1	1	CD
cord-030594-xhp8kin0	10	3	]	]	-RRB-
cord-030594-xhp8kin0	10	4	On	on	IN
cord-030594-xhp8kin0	10	5	the	the	DT
cord-030594-xhp8kin0	10	6	other	other	JJ
cord-030594-xhp8kin0	10	7	hand	hand	NN
cord-030594-xhp8kin0	10	8	,	,	,
cord-030594-xhp8kin0	10	9	serum	serum	NN
cord-030594-xhp8kin0	10	10	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	10	11	plays	play	VBZ
cord-030594-xhp8kin0	10	12	an	an	DT
cord-030594-xhp8kin0	10	13	important	important	JJ
cord-030594-xhp8kin0	10	14	role	role	NN
cord-030594-xhp8kin0	10	15	in	in	IN
cord-030594-xhp8kin0	10	16	the	the	DT
cord-030594-xhp8kin0	10	17	inflammatory	inflammatory	JJ
cord-030594-xhp8kin0	10	18	response	response	NN
cord-030594-xhp8kin0	10	19	and	and	CC
cord-030594-xhp8kin0	10	20	may	may	MD
cord-030594-xhp8kin0	10	21	be	be	VB
cord-030594-xhp8kin0	10	22	associated	associate	VBN
cord-030594-xhp8kin0	10	23	with	with	IN
cord-030594-xhp8kin0	10	24	prognosis	prognosis	NN
cord-030594-xhp8kin0	10	25	in	in	IN
cord-030594-xhp8kin0	10	26	sepsis	sepsis	NN
cord-030594-xhp8kin0	10	27	.	.	.
cord-030594-xhp8kin0	11	1	[	[	-LRB-
cord-030594-xhp8kin0	11	2	2	2	LS
cord-030594-xhp8kin0	11	3	]	]	-RRB-
cord-030594-xhp8kin0	11	4	[	[	-LRB-
cord-030594-xhp8kin0	11	5	3	3	CD
cord-030594-xhp8kin0	11	6	]	]	-RRB-
cord-030594-xhp8kin0	11	7	[	[	-LRB-
cord-030594-xhp8kin0	11	8	4	4	LS
cord-030594-xhp8kin0	11	9	]	]	-RRB-
cord-030594-xhp8kin0	11	10	We	-PRON-	PRP
cord-030594-xhp8kin0	11	11	focused	focus	VBD
cord-030594-xhp8kin0	11	12	on	on	IN
cord-030594-xhp8kin0	11	13	the	the	DT
cord-030594-xhp8kin0	11	14	similarities	similarity	NNS
cord-030594-xhp8kin0	11	15	between	between	IN
cord-030594-xhp8kin0	11	16	severe	severe	JJ
cord-030594-xhp8kin0	11	17	COVID-19	covid-19	JJ
cord-030594-xhp8kin0	11	18	pneumonia	pneumonia	NN
cord-030594-xhp8kin0	11	19	and	and	CC
cord-030594-xhp8kin0	11	20	sepsis	sepsis	NN
cord-030594-xhp8kin0	11	21	.	.	.
cord-030594-xhp8kin0	12	1	We	-PRON-	PRP
cord-030594-xhp8kin0	12	2	examined	examine	VBD
cord-030594-xhp8kin0	12	3	associations	association	NNS
cord-030594-xhp8kin0	12	4	between	between	IN
cord-030594-xhp8kin0	12	5	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	12	6	levels	level	NNS
cord-030594-xhp8kin0	12	7	on	on	IN
cord-030594-xhp8kin0	12	8	admission	admission	NN
cord-030594-xhp8kin0	12	9	and	and	CC
cord-030594-xhp8kin0	12	10	the	the	DT
cord-030594-xhp8kin0	12	11	severity	severity	NN
cord-030594-xhp8kin0	12	12	,	,	,
cord-030594-xhp8kin0	12	13	and	and	CC
cord-030594-xhp8kin0	12	14	mortality	mortality	NN
cord-030594-xhp8kin0	12	15	of	of	IN
cord-030594-xhp8kin0	12	16	patients	patient	NNS
cord-030594-xhp8kin0	12	17	with	with	IN
cord-030594-xhp8kin0	12	18	COVID-19	COVID-19	NNP
cord-030594-xhp8kin0	12	19	pneumonia	pneumonia	NN
cord-030594-xhp8kin0	12	20	,	,	,
cord-030594-xhp8kin0	12	21	as	as	RB
cord-030594-xhp8kin0	12	22	well	well	RB
cord-030594-xhp8kin0	12	23	as	as	IN
cord-030594-xhp8kin0	12	24	the	the	DT
cord-030594-xhp8kin0	12	25	interaction	interaction	NN
cord-030594-xhp8kin0	12	26	between	between	IN
cord-030594-xhp8kin0	12	27	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	12	28	and	and	CC
cord-030594-xhp8kin0	12	29	the	the	DT
cord-030594-xhp8kin0	12	30	previously	previously	RB
cord-030594-xhp8kin0	12	31	reported	report	VBN
cord-030594-xhp8kin0	12	32	factors	factor	NNS
cord-030594-xhp8kin0	12	33	of	of	IN
cord-030594-xhp8kin0	12	34	severity	severity	NN
cord-030594-xhp8kin0	12	35	and	and	CC
cord-030594-xhp8kin0	12	36	mortality	mortality	NN
cord-030594-xhp8kin0	12	37	.	.	.
cord-030594-xhp8kin0	13	1	We	-PRON-	PRP
cord-030594-xhp8kin0	13	2	included	include	VBD
cord-030594-xhp8kin0	13	3	patients	patient	NNS
cord-030594-xhp8kin0	13	4	who	who	WP
cord-030594-xhp8kin0	13	5	had	have	VBD
cord-030594-xhp8kin0	13	6	tested	test	VBN
cord-030594-xhp8kin0	13	7	positive	positive	JJ
cord-030594-xhp8kin0	13	8	for	for	IN
cord-030594-xhp8kin0	13	9	severe	severe	JJ
cord-030594-xhp8kin0	13	10	acute	acute	JJ
cord-030594-xhp8kin0	13	11	respiratory	respiratory	JJ
cord-030594-xhp8kin0	13	12	syndrome	syndrome	NN
cord-030594-xhp8kin0	13	13	coronavirus	coronavirus	NN
cord-030594-xhp8kin0	13	14	2	2	CD
cord-030594-xhp8kin0	13	15	from	from	IN
cord-030594-xhp8kin0	13	16	February	February	NNP
cord-030594-xhp8kin0	13	17	to	to	IN
cord-030594-xhp8kin0	13	18	May	May	NNP
cord-030594-xhp8kin0	13	19	2020	2020	CD
cord-030594-xhp8kin0	13	20	at	at	IN
cord-030594-xhp8kin0	13	21	Yokohama	Yokohama	NNP
cord-030594-xhp8kin0	13	22	City	City	NNP
cord-030594-xhp8kin0	13	23	University	University	NNP
cord-030594-xhp8kin0	13	24	Hospital	Hospital	NNP
cord-030594-xhp8kin0	13	25	and	and	CC
cord-030594-xhp8kin0	13	26	Yokohama	Yokohama	NNP
cord-030594-xhp8kin0	13	27	City	City	NNP
cord-030594-xhp8kin0	13	28	University	University	NNP
cord-030594-xhp8kin0	13	29	Medical	Medical	NNP
cord-030594-xhp8kin0	13	30	Center	Center	NNP
cord-030594-xhp8kin0	13	31	.	.	.
cord-030594-xhp8kin0	14	1	Ultimately	ultimately	RB
cord-030594-xhp8kin0	14	2	,	,	,
cord-030594-xhp8kin0	14	3	26	26	CD
cord-030594-xhp8kin0	14	4	patients	patient	NNS
cord-030594-xhp8kin0	14	5	were	be	VBD
cord-030594-xhp8kin0	14	6	included	include	VBN
cord-030594-xhp8kin0	14	7	in	in	IN
cord-030594-xhp8kin0	14	8	the	the	DT
cord-030594-xhp8kin0	14	9	study	study	NN
cord-030594-xhp8kin0	14	10	.	.	.
cord-030594-xhp8kin0	15	1	Outcomes	outcome	NNS
cord-030594-xhp8kin0	15	2	were	be	VBD
cord-030594-xhp8kin0	15	3	aggravation	aggravation	NN
cord-030594-xhp8kin0	15	4	of	of	IN
cord-030594-xhp8kin0	15	5	symptoms	symptom	NNS
cord-030594-xhp8kin0	15	6	and	and	CC
cord-030594-xhp8kin0	15	7	in	in	IN
cord-030594-xhp8kin0	15	8	-	-	HYPH
cord-030594-xhp8kin0	15	9	hospital	hospital	NN
cord-030594-xhp8kin0	15	10	death	death	NN
cord-030594-xhp8kin0	15	11	.	.	.
cord-030594-xhp8kin0	16	1	The	the	DT
cord-030594-xhp8kin0	16	2	clinical	clinical	JJ
cord-030594-xhp8kin0	16	3	characteristics	characteristic	NNS
cord-030594-xhp8kin0	16	4	of	of	IN
cord-030594-xhp8kin0	16	5	the	the	DT
cord-030594-xhp8kin0	16	6	patients	patient	NNS
cord-030594-xhp8kin0	16	7	grouped	group	VBN
cord-030594-xhp8kin0	16	8	by	by	IN
cord-030594-xhp8kin0	16	9	severity	severity	NN
cord-030594-xhp8kin0	16	10	are	be	VBP
cord-030594-xhp8kin0	16	11	shown	show	VBN
cord-030594-xhp8kin0	16	12	in	in	IN
cord-030594-xhp8kin0	16	13	Table	Table	NNP
cord-030594-xhp8kin0	16	14	1	1	CD
cord-030594-xhp8kin0	16	15	.	.	.
cord-030594-xhp8kin0	17	1	There	there	EX
cord-030594-xhp8kin0	17	2	was	be	VBD
cord-030594-xhp8kin0	17	3	no	no	DT
cord-030594-xhp8kin0	17	4	significant	significant	JJ
cord-030594-xhp8kin0	17	5	difference	difference	NN
cord-030594-xhp8kin0	17	6	in	in	IN
cord-030594-xhp8kin0	17	7	patient	patient	JJ
cord-030594-xhp8kin0	17	8	characteristics	characteristic	NNS
cord-030594-xhp8kin0	17	9	between	between	IN
cord-030594-xhp8kin0	17	10	the	the	DT
cord-030594-xhp8kin0	17	11	groups	group	NNS
cord-030594-xhp8kin0	17	12	.	.	.
cord-030594-xhp8kin0	18	1	Supplementary	Supplementary	NNP
cord-030594-xhp8kin0	18	2	Materials	material	NNS
cord-030594-xhp8kin0	18	3	1	1	CD
cord-030594-xhp8kin0	18	4	shows	show	VBZ
cord-030594-xhp8kin0	18	5	the	the	DT
cord-030594-xhp8kin0	18	6	time	time	NN
cord-030594-xhp8kin0	18	7	course	course	NN
cord-030594-xhp8kin0	18	8	of	of	IN
cord-030594-xhp8kin0	18	9	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	18	10	and	and	CC
cord-030594-xhp8kin0	18	11	other	other	JJ
cord-030594-xhp8kin0	18	12	factors	factor	NNS
cord-030594-xhp8kin0	18	13	in	in	IN
cord-030594-xhp8kin0	18	14	critically	critically	RB
cord-030594-xhp8kin0	18	15	ill	ill	JJ
cord-030594-xhp8kin0	18	16	patients	patient	NNS
cord-030594-xhp8kin0	18	17	with	with	IN
cord-030594-xhp8kin0	18	18	good	good	JJ
cord-030594-xhp8kin0	18	19	outcome	outcome	NN
cord-030594-xhp8kin0	18	20	and	and	CC
cord-030594-xhp8kin0	18	21	death	death	NN
cord-030594-xhp8kin0	18	22	.	.	.
cord-030594-xhp8kin0	19	1	In	in	IN
cord-030594-xhp8kin0	19	2	critically	critically	RB
cord-030594-xhp8kin0	19	3	ill	ill	JJ
cord-030594-xhp8kin0	19	4	patients	patient	NNS
cord-030594-xhp8kin0	19	5	with	with	IN
cord-030594-xhp8kin0	19	6	favorable	favorable	JJ
cord-030594-xhp8kin0	19	7	outcome	outcome	NN
cord-030594-xhp8kin0	19	8	,	,	,
cord-030594-xhp8kin0	19	9	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	19	10	,	,	,
cord-030594-xhp8kin0	19	11	lymphocytes	lymphocyte	NNS
cord-030594-xhp8kin0	19	12	,	,	,
cord-030594-xhp8kin0	19	13	albumin	albumin	NN
cord-030594-xhp8kin0	19	14	,	,	,
cord-030594-xhp8kin0	19	15	and	and	CC
cord-030594-xhp8kin0	19	16	PaO	pao	NN
cord-030594-xhp8kin0	19	17	2	2	CD
cord-030594-xhp8kin0	19	18	/FiO	/fio	SYM
cord-030594-xhp8kin0	19	19	2	2	CD
cord-030594-xhp8kin0	19	20	ratio	ratio	NN
cord-030594-xhp8kin0	19	21	decreased	decrease	VBD
cord-030594-xhp8kin0	19	22	but	but	CC
cord-030594-xhp8kin0	19	23	C	c	NN
cord-030594-xhp8kin0	19	24	-	-	HYPH
cord-030594-xhp8kin0	19	25	reactive	reactive	JJ
cord-030594-xhp8kin0	19	26	protein	protein	NN
cord-030594-xhp8kin0	19	27	increased	increase	VBD
cord-030594-xhp8kin0	19	28	toward	toward	IN
cord-030594-xhp8kin0	19	29	the	the	DT
cord-030594-xhp8kin0	19	30	peak	peak	NN
cord-030594-xhp8kin0	19	31	of	of	IN
cord-030594-xhp8kin0	19	32	inflammation	inflammation	NN
cord-030594-xhp8kin0	19	33	.	.	.
cord-030594-xhp8kin0	20	1	Later	later	RB
cord-030594-xhp8kin0	20	2	,	,	,
cord-030594-xhp8kin0	20	3	C	c	NN
cord-030594-xhp8kin0	20	4	-	-	HYPH
cord-030594-xhp8kin0	20	5	reactive	reactive	JJ
cord-030594-xhp8kin0	20	6	protein	protein	NN
cord-030594-xhp8kin0	20	7	decreased	decrease	VBD
cord-030594-xhp8kin0	20	8	with	with	IN
cord-030594-xhp8kin0	20	9	improvement	improvement	NN
cord-030594-xhp8kin0	20	10	in	in	IN
cord-030594-xhp8kin0	20	11	inflammation	inflammation	NN
cord-030594-xhp8kin0	20	12	,	,	,
cord-030594-xhp8kin0	20	13	but	but	CC
cord-030594-xhp8kin0	20	14	there	there	EX
cord-030594-xhp8kin0	20	15	was	be	VBD
cord-030594-xhp8kin0	20	16	a	a	DT
cord-030594-xhp8kin0	20	17	tendency	tendency	NN
cord-030594-xhp8kin0	20	18	for	for	IN
cord-030594-xhp8kin0	20	19	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	20	20	,	,	,
cord-030594-xhp8kin0	20	21	lymphocytes	lymphocyte	NNS
cord-030594-xhp8kin0	20	22	,	,	,
cord-030594-xhp8kin0	20	23	albumin	albumin	NN
cord-030594-xhp8kin0	20	24	,	,	,
cord-030594-xhp8kin0	20	25	and	and	CC
cord-030594-xhp8kin0	20	26	PaO	pao	NN
cord-030594-xhp8kin0	20	27	2	2	CD
cord-030594-xhp8kin0	20	28	/FiO	/fio	SYM
cord-030594-xhp8kin0	20	29	2	2	CD
cord-030594-xhp8kin0	20	30	ratio	ratio	NN
cord-030594-xhp8kin0	20	31	to	to	TO
cord-030594-xhp8kin0	20	32	increase	increase	VB
cord-030594-xhp8kin0	20	33	.	.	.
cord-030594-xhp8kin0	21	1	In	in	IN
cord-030594-xhp8kin0	21	2	contrast	contrast	NN
cord-030594-xhp8kin0	21	3	,	,	,
cord-030594-xhp8kin0	21	4	in	in	IN
cord-030594-xhp8kin0	21	5	the	the	DT
cord-030594-xhp8kin0	21	6	severely	severely	RB
cord-030594-xhp8kin0	21	7	ill	ill	JJ
cord-030594-xhp8kin0	21	8	patient	patient	NN
cord-030594-xhp8kin0	21	9	who	who	WP
cord-030594-xhp8kin0	21	10	died	die	VBD
cord-030594-xhp8kin0	21	11	,	,	,
cord-030594-xhp8kin0	21	12	C	C	NNP
cord-030594-xhp8kin0	21	13	-	-	HYPH
cord-030594-xhp8kin0	21	14	reactive	reactive	JJ
cord-030594-xhp8kin0	21	15	protein	protein	NN
cord-030594-xhp8kin0	21	16	poorly	poorly	RB
cord-030594-xhp8kin0	21	17	decreased	decrease	VBD
cord-030594-xhp8kin0	21	18	,	,	,
cord-030594-xhp8kin0	21	19	and	and	CC
cord-030594-xhp8kin0	21	20	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	21	21	,	,	,
cord-030594-xhp8kin0	21	22	lymphocytes	lymphocyte	NNS
cord-030594-xhp8kin0	21	23	,	,	,
cord-030594-xhp8kin0	21	24	albumin	albumin	NN
cord-030594-xhp8kin0	21	25	,	,	,
cord-030594-xhp8kin0	21	26	and	and	CC
cord-030594-xhp8kin0	21	27	PaO	pao	NN
cord-030594-xhp8kin0	21	28	2	2	CD
cord-030594-xhp8kin0	22	1	/FiO	/FiO	NFP
cord-030594-xhp8kin0	22	2	2	2	CD
cord-030594-xhp8kin0	22	3	ratio	ratio	NN
cord-030594-xhp8kin0	22	4	were	be	VBD
cord-030594-xhp8kin0	22	5	not	not	RB
cord-030594-xhp8kin0	22	6	elevated	elevated	JJ
cord-030594-xhp8kin0	22	7	.	.	.
cord-030594-xhp8kin0	23	1	Our	-PRON-	PRP$
cord-030594-xhp8kin0	23	2	results	result	NNS
cord-030594-xhp8kin0	23	3	demonstrate	demonstrate	VBP
cord-030594-xhp8kin0	23	4	that	that	IN
cord-030594-xhp8kin0	23	5	the	the	DT
cord-030594-xhp8kin0	23	6	potential	potential	NN
cord-030594-xhp8kin0	23	7	of	of	IN
cord-030594-xhp8kin0	23	8	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	23	9	levels	level	NNS
cord-030594-xhp8kin0	23	10	and	and	CC
cord-030594-xhp8kin0	23	11	their	-PRON-	PRP$
cord-030594-xhp8kin0	23	12	interactions	interaction	NNS
cord-030594-xhp8kin0	23	13	were	be	VBD
cord-030594-xhp8kin0	23	14	significantly	significantly	RB
cord-030594-xhp8kin0	23	15	associated	associate	VBN
cord-030594-xhp8kin0	23	16	with	with	IN
cord-030594-xhp8kin0	23	17	severity	severity	NN
cord-030594-xhp8kin0	23	18	and	and	CC
cord-030594-xhp8kin0	23	19	mortality	mortality	NN
cord-030594-xhp8kin0	23	20	in	in	IN
cord-030594-xhp8kin0	23	21	COVID-19	covid-19	JJ
cord-030594-xhp8kin0	23	22	pneumonia	pneumonia	NN
cord-030594-xhp8kin0	23	23	patients	patient	NNS
cord-030594-xhp8kin0	23	24	.	.	.
cord-030594-xhp8kin0	24	1	Cholinesterase	Cholinesterase	NNP
cord-030594-xhp8kin0	24	2	is	be	VBZ
cord-030594-xhp8kin0	24	3	an	an	DT
cord-030594-xhp8kin0	24	4	enzyme	enzyme	NN
cord-030594-xhp8kin0	24	5	produced	produce	VBN
cord-030594-xhp8kin0	24	6	in	in	IN
cord-030594-xhp8kin0	24	7	the	the	DT
cord-030594-xhp8kin0	24	8	liver	liver	NN
cord-030594-xhp8kin0	24	9	that	that	WDT
cord-030594-xhp8kin0	24	10	hydrolyzes	hydrolyze	VBZ
cord-030594-xhp8kin0	24	11	cholinesters	cholinester	NNS
cord-030594-xhp8kin0	24	12	,	,	,
cord-030594-xhp8kin0	24	13	and	and	CC
cord-030594-xhp8kin0	24	14	measured	measure	VBN
cord-030594-xhp8kin0	24	15	as	as	IN
cord-030594-xhp8kin0	24	16	a	a	DT
cord-030594-xhp8kin0	24	17	liver	liver	NN
cord-030594-xhp8kin0	24	18	function	function	NN
cord-030594-xhp8kin0	24	19	test	test	NN
cord-030594-xhp8kin0	24	20	.	.	.
cord-030594-xhp8kin0	25	1	Cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	25	2	levels	level	NNS
cord-030594-xhp8kin0	25	3	are	be	VBP
cord-030594-xhp8kin0	25	4	high	high	JJ
cord-030594-xhp8kin0	25	5	in	in	IN
cord-030594-xhp8kin0	25	6	patients	patient	NNS
cord-030594-xhp8kin0	25	7	with	with	IN
cord-030594-xhp8kin0	25	8	nephrotic	nephrotic	JJ
cord-030594-xhp8kin0	25	9	syndrome	syndrome	NN
cord-030594-xhp8kin0	25	10	,	,	,
cord-030594-xhp8kin0	25	11	diabetes	diabetes	NN
cord-030594-xhp8kin0	25	12	,	,	,
cord-030594-xhp8kin0	25	13	hyperthyroidism	hyperthyroidism	NN
cord-030594-xhp8kin0	25	14	,	,	,
cord-030594-xhp8kin0	25	15	fatty	fatty	JJ
cord-030594-xhp8kin0	25	16	liver	liver	NN
cord-030594-xhp8kin0	25	17	,	,	,
cord-030594-xhp8kin0	25	18	dyslipidemia	dyslipidemia	NN
cord-030594-xhp8kin0	25	19	,	,	,
cord-030594-xhp8kin0	25	20	and	and	CC
cord-030594-xhp8kin0	25	21	obesity	obesity	NN
cord-030594-xhp8kin0	25	22	and	and	CC
cord-030594-xhp8kin0	25	23	low	low	JJ
cord-030594-xhp8kin0	25	24	in	in	IN
cord-030594-xhp8kin0	25	25	patients	patient	NNS
cord-030594-xhp8kin0	25	26	with	with	IN
cord-030594-xhp8kin0	25	27	liver	liver	NN
cord-030594-xhp8kin0	25	28	cirrhosis	cirrhosis	NN
cord-030594-xhp8kin0	25	29	,	,	,
cord-030594-xhp8kin0	25	30	hepatitis	hepatitis	NN
cord-030594-xhp8kin0	25	31	,	,	,
cord-030594-xhp8kin0	25	32	malignant	malignant	JJ
cord-030594-xhp8kin0	25	33	tumor	tumor	NN
cord-030594-xhp8kin0	25	34	,	,	,
cord-030594-xhp8kin0	25	35	malnutrition	malnutrition	NN
cord-030594-xhp8kin0	25	36	,	,	,
cord-030594-xhp8kin0	25	37	sepsis	sepsis	NN
cord-030594-xhp8kin0	25	38	,	,	,
cord-030594-xhp8kin0	25	39	and	and	CC
cord-030594-xhp8kin0	25	40	organophosphate	organophosphate	NN
cord-030594-xhp8kin0	25	41	poisoning	poisoning	NN
cord-030594-xhp8kin0	25	42	.	.	.
cord-030594-xhp8kin0	26	1	[	[	-LRB-
cord-030594-xhp8kin0	26	2	5	5	CD
cord-030594-xhp8kin0	26	3	]	]	-RRB-
cord-030594-xhp8kin0	27	1	Although	although	IN
cord-030594-xhp8kin0	27	2	the	the	DT
cord-030594-xhp8kin0	27	3	mechanism	mechanism	NN
cord-030594-xhp8kin0	27	4	underlying	underlie	VBG
cord-030594-xhp8kin0	27	5	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	27	6	reduction	reduction	NN
cord-030594-xhp8kin0	27	7	in	in	IN
cord-030594-xhp8kin0	27	8	sepsis	sepsis	NN
cord-030594-xhp8kin0	27	9	has	have	VBZ
cord-030594-xhp8kin0	27	10	not	not	RB
cord-030594-xhp8kin0	27	11	yet	yet	RB
cord-030594-xhp8kin0	27	12	been	be	VBN
cord-030594-xhp8kin0	27	13	determined	determine	VBN
cord-030594-xhp8kin0	27	14	,	,	,
cord-030594-xhp8kin0	27	15	it	-PRON-	PRP
cord-030594-xhp8kin0	27	16	is	be	VBZ
cord-030594-xhp8kin0	27	17	thought	think	VBN
cord-030594-xhp8kin0	27	18	to	to	TO
cord-030594-xhp8kin0	27	19	be	be	VB
cord-030594-xhp8kin0	27	20	affected	affect	VBN
cord-030594-xhp8kin0	27	21	by	by	IN
cord-030594-xhp8kin0	27	22	acute	acute	JJ
cord-030594-xhp8kin0	27	23	-	-	HYPH
cord-030594-xhp8kin0	27	24	phase	phase	NN
cord-030594-xhp8kin0	27	25	infections	infection	NNS
cord-030594-xhp8kin0	27	26	and	and	CC
cord-030594-xhp8kin0	27	27	inflammatory	inflammatory	JJ
cord-030594-xhp8kin0	27	28	processes	process	NNS
cord-030594-xhp8kin0	27	29	.	.	.
cord-030594-xhp8kin0	28	1	[	[	-LRB-
cord-030594-xhp8kin0	28	2	6	6	LS
cord-030594-xhp8kin0	28	3	]	]	-RRB-
cord-030594-xhp8kin0	28	4	It	-PRON-	PRP
cord-030594-xhp8kin0	28	5	has	have	VBZ
cord-030594-xhp8kin0	28	6	been	be	VBN
cord-030594-xhp8kin0	28	7	hypothesized	hypothesize	VBN
cord-030594-xhp8kin0	28	8	that	that	IN
cord-030594-xhp8kin0	28	9	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	28	10	synthesis	synthesis	NN
cord-030594-xhp8kin0	28	11	decreases	decrease	VBZ
cord-030594-xhp8kin0	28	12	owing	owe	VBG
cord-030594-xhp8kin0	28	13	to	to	IN
cord-030594-xhp8kin0	28	14	hepatic	hepatic	JJ
cord-030594-xhp8kin0	28	15	dysfunction	dysfunction	NN
cord-030594-xhp8kin0	28	16	with	with	IN
cord-030594-xhp8kin0	28	17	disease	disease	NN
cord-030594-xhp8kin0	28	18	progression	progression	NN
cord-030594-xhp8kin0	28	19	,	,	,
cord-030594-xhp8kin0	28	20	capillary	capillary	JJ
cord-030594-xhp8kin0	28	21	permeability	permeability	NN
cord-030594-xhp8kin0	28	22	enhancement	enhancement	NN
cord-030594-xhp8kin0	28	23	,	,	,
cord-030594-xhp8kin0	28	24	dilution	dilution	NN
cord-030594-xhp8kin0	28	25	with	with	IN
cord-030594-xhp8kin0	28	26	fluid	fluid	JJ
cord-030594-xhp8kin0	28	27	challenges	challenge	NNS
cord-030594-xhp8kin0	28	28	,	,	,
cord-030594-xhp8kin0	28	29	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	28	30	catabolism	catabolism	NN
cord-030594-xhp8kin0	28	31	enhancement	enhancement	NN
cord-030594-xhp8kin0	28	32	,	,	,
cord-030594-xhp8kin0	28	33	and	and	CC
cord-030594-xhp8kin0	28	34	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	28	35	inhibition	inhibition	NN
cord-030594-xhp8kin0	28	36	by	by	IN
cord-030594-xhp8kin0	28	37	inflammatory	inflammatory	JJ
cord-030594-xhp8kin0	28	38	mediators	mediator	NNS
cord-030594-xhp8kin0	28	39	(	(	-LRB-
cord-030594-xhp8kin0	28	40	cytokines	cytokine	NNS
cord-030594-xhp8kin0	28	41	)	)	-RRB-
cord-030594-xhp8kin0	28	42	.	.	.
cord-030594-xhp8kin0	29	1	[	[	-LRB-
cord-030594-xhp8kin0	29	2	7	7	CD
cord-030594-xhp8kin0	29	3	]	]	-RRB-
cord-030594-xhp8kin0	29	4	Levels	level	NNS
cord-030594-xhp8kin0	29	5	of	of	IN
cord-030594-xhp8kin0	29	6	"	"	``
cord-030594-xhp8kin0	29	7	positive	positive	JJ
cord-030594-xhp8kin0	29	8	"	"	''
cord-030594-xhp8kin0	29	9	acute	acute	JJ
cord-030594-xhp8kin0	29	10	-	-	HYPH
cord-030594-xhp8kin0	29	11	phase	phase	NN
cord-030594-xhp8kin0	29	12	proteins	protein	NNS
cord-030594-xhp8kin0	29	13	such	such	JJ
cord-030594-xhp8kin0	29	14	as	as	IN
cord-030594-xhp8kin0	29	15	C	C	NNP
cord-030594-xhp8kin0	29	16	-	-	HYPH
cord-030594-xhp8kin0	29	17	reactive	reactive	JJ
cord-030594-xhp8kin0	29	18	protein	protein	NN
cord-030594-xhp8kin0	29	19	,	,	,
cord-030594-xhp8kin0	29	20	amyloid	amyloid	NNP
cord-030594-xhp8kin0	29	21	A	A	NNP
cord-030594-xhp8kin0	29	22	,	,	,
cord-030594-xhp8kin0	29	23	and	and	CC
cord-030594-xhp8kin0	29	24	ferritin	ferritin	NN
cord-030594-xhp8kin0	29	25	generally	generally	RB
cord-030594-xhp8kin0	29	26	increase	increase	VBP
cord-030594-xhp8kin0	29	27	in	in	IN
cord-030594-xhp8kin0	29	28	patients	patient	NNS
cord-030594-xhp8kin0	29	29	with	with	IN
cord-030594-xhp8kin0	29	30	inflammatory	inflammatory	JJ
cord-030594-xhp8kin0	29	31	diseases	disease	NNS
cord-030594-xhp8kin0	29	32	.	.	.
cord-030594-xhp8kin0	30	1	In	in	IN
cord-030594-xhp8kin0	30	2	contrast	contrast	NN
cord-030594-xhp8kin0	30	3	,	,	,
cord-030594-xhp8kin0	30	4	levels	level	NNS
cord-030594-xhp8kin0	30	5	of	of	IN
cord-030594-xhp8kin0	30	6	"	"	``
cord-030594-xhp8kin0	30	7	negative	negative	JJ
cord-030594-xhp8kin0	30	8	"	"	''
cord-030594-xhp8kin0	30	9	acute	acute	JJ
cord-030594-xhp8kin0	30	10	-	-	HYPH
cord-030594-xhp8kin0	30	11	phase	phase	NN
cord-030594-xhp8kin0	30	12	proteins	protein	NNS
cord-030594-xhp8kin0	30	13	such	such	JJ
cord-030594-xhp8kin0	30	14	as	as	IN
cord-030594-xhp8kin0	30	15	albumin	albumin	NN
cord-030594-xhp8kin0	30	16	,	,	,
cord-030594-xhp8kin0	30	17	prealbumin	prealbumin	NNP
cord-030594-xhp8kin0	30	18	,	,	,
cord-030594-xhp8kin0	30	19	and	and	CC
cord-030594-xhp8kin0	30	20	transferrin	transferrin	NN
cord-030594-xhp8kin0	30	21	decrease	decrease	NN
cord-030594-xhp8kin0	30	22	in	in	IN
cord-030594-xhp8kin0	30	23	response	response	NN
cord-030594-xhp8kin0	30	24	to	to	IN
cord-030594-xhp8kin0	30	25	inflammation	inflammation	NN
cord-030594-xhp8kin0	30	26	and	and	CC
cord-030594-xhp8kin0	30	27	increase	increase	NN
cord-030594-xhp8kin0	30	28	during	during	IN
cord-030594-xhp8kin0	30	29	the	the	DT
cord-030594-xhp8kin0	30	30	recovery	recovery	NN
cord-030594-xhp8kin0	30	31	period	period	NN
cord-030594-xhp8kin0	30	32	.	.	.
cord-030594-xhp8kin0	31	1	[	[	-LRB-
cord-030594-xhp8kin0	31	2	2	2	CD
cord-030594-xhp8kin0	31	3	,	,	,
cord-030594-xhp8kin0	31	4	8	8	CD
cord-030594-xhp8kin0	31	5	]	]	-RRB-
cord-030594-xhp8kin0	31	6	Cholinesterase	Cholinesterase	NNP
cord-030594-xhp8kin0	31	7	and	and	CC
cord-030594-xhp8kin0	31	8	lymphocytes	lymphocyte	NNS
cord-030594-xhp8kin0	31	9	behave	behave	VBP
cord-030594-xhp8kin0	31	10	similar	similar	JJ
cord-030594-xhp8kin0	31	11	to	to	IN
cord-030594-xhp8kin0	31	12	the	the	DT
cord-030594-xhp8kin0	31	13	"	"	``
cord-030594-xhp8kin0	31	14	negative	negative	JJ
cord-030594-xhp8kin0	31	15	"	"	''
cord-030594-xhp8kin0	31	16	acute	acute	JJ
cord-030594-xhp8kin0	31	17	-	-	HYPH
cord-030594-xhp8kin0	31	18	phase	phase	NN
cord-030594-xhp8kin0	31	19	proteins	protein	NNS
cord-030594-xhp8kin0	31	20	in	in	IN
cord-030594-xhp8kin0	31	21	response	response	NN
cord-030594-xhp8kin0	31	22	to	to	IN
cord-030594-xhp8kin0	31	23	inflammation	inflammation	NN
cord-030594-xhp8kin0	31	24	.	.	.
cord-030594-xhp8kin0	32	1	[	[	-LRB-
cord-030594-xhp8kin0	32	2	9	9	CD
cord-030594-xhp8kin0	32	3	,	,	,
cord-030594-xhp8kin0	32	4	10	10	CD
cord-030594-xhp8kin0	32	5	]	]	-RRB-
cord-030594-xhp8kin0	32	6	Even	even	RB
cord-030594-xhp8kin0	32	7	in	in	IN
cord-030594-xhp8kin0	32	8	patients	patient	NNS
cord-030594-xhp8kin0	32	9	with	with	IN
cord-030594-xhp8kin0	32	10	COVID-19	COVID-19	NNP
cord-030594-xhp8kin0	32	11	pneumonia	pneumonia	NN
cord-030594-xhp8kin0	32	12	,	,	,
cord-030594-xhp8kin0	32	13	amyloid	amyloid	NNP
cord-030594-xhp8kin0	32	14	A	A	NNP
cord-030594-xhp8kin0	32	15	,	,	,
cord-030594-xhp8kin0	32	16	which	which	WDT
cord-030594-xhp8kin0	32	17	is	be	VBZ
cord-030594-xhp8kin0	32	18	classified	classify	VBN
cord-030594-xhp8kin0	32	19	as	as	IN
cord-030594-xhp8kin0	32	20	a	a	DT
cord-030594-xhp8kin0	32	21	"	"	``
cord-030594-xhp8kin0	32	22	positive	positive	JJ
cord-030594-xhp8kin0	32	23	"	"	''
cord-030594-xhp8kin0	32	24	acute	acute	JJ
cord-030594-xhp8kin0	32	25	-	-	HYPH
cord-030594-xhp8kin0	32	26	phase	phase	NN
cord-030594-xhp8kin0	32	27	protein	protein	NN
cord-030594-xhp8kin0	32	28	;	;	:
cord-030594-xhp8kin0	32	29	albumin	albumin	NN
cord-030594-xhp8kin0	32	30	,	,	,
cord-030594-xhp8kin0	32	31	which	which	WDT
cord-030594-xhp8kin0	32	32	is	be	VBZ
cord-030594-xhp8kin0	32	33	classified	classify	VBN
cord-030594-xhp8kin0	32	34	as	as	IN
cord-030594-xhp8kin0	32	35	a	a	DT
cord-030594-xhp8kin0	32	36	"	"	``
cord-030594-xhp8kin0	32	37	negative	negative	JJ
cord-030594-xhp8kin0	32	38	"	"	''
cord-030594-xhp8kin0	32	39	acute	acute	JJ
cord-030594-xhp8kin0	32	40	-	-	HYPH
cord-030594-xhp8kin0	32	41	phase	phase	NN
cord-030594-xhp8kin0	32	42	protein	protein	NN
cord-030594-xhp8kin0	32	43	;	;	:
cord-030594-xhp8kin0	32	44	and	and	CC
cord-030594-xhp8kin0	32	45	lymphocytes	lymphocyte	NNS
cord-030594-xhp8kin0	32	46	showing	show	VBG
cord-030594-xhp8kin0	32	47	similar	similar	JJ
cord-030594-xhp8kin0	32	48	reactions	reaction	NNS
cord-030594-xhp8kin0	32	49	as	as	IN
cord-030594-xhp8kin0	32	50	those	those	DT
cord-030594-xhp8kin0	32	51	of	of	IN
cord-030594-xhp8kin0	32	52	"	"	``
cord-030594-xhp8kin0	32	53	negative	negative	JJ
cord-030594-xhp8kin0	32	54	"	"	''
cord-030594-xhp8kin0	32	55	acute	acute	JJ
cord-030594-xhp8kin0	32	56	-	-	HYPH
cord-030594-xhp8kin0	32	57	phase	phase	NN
cord-030594-xhp8kin0	32	58	proteins	protein	NNS
cord-030594-xhp8kin0	32	59	against	against	IN
cord-030594-xhp8kin0	32	60	inflammation	inflammation	NN
cord-030594-xhp8kin0	32	61	have	have	VBP
cord-030594-xhp8kin0	32	62	been	be	VBN
cord-030594-xhp8kin0	32	63	suggested	suggest	VBN
cord-030594-xhp8kin0	32	64	to	to	TO
cord-030594-xhp8kin0	32	65	be	be	VB
cord-030594-xhp8kin0	32	66	related	relate	VBN
cord-030594-xhp8kin0	32	67	to	to	IN
cord-030594-xhp8kin0	32	68	severity	severity	NN
cord-030594-xhp8kin0	32	69	.	.	.
cord-030594-xhp8kin0	33	1	[	[	-LRB-
cord-030594-xhp8kin0	33	2	4	4	CD
cord-030594-xhp8kin0	33	3	]	]	-RRB-
cord-030594-xhp8kin0	34	1	Our	-PRON-	PRP$
cord-030594-xhp8kin0	34	2	study	study	NN
cord-030594-xhp8kin0	34	3	suggests	suggest	VBZ
cord-030594-xhp8kin0	34	4	that	that	IN
cord-030594-xhp8kin0	34	5	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	34	6	,	,	,
cord-030594-xhp8kin0	34	7	which	which	WDT
cord-030594-xhp8kin0	34	8	responds	respond	VBZ
cord-030594-xhp8kin0	34	9	similar	similar	JJ
cord-030594-xhp8kin0	34	10	to	to	IN
cord-030594-xhp8kin0	34	11	the	the	DT
cord-030594-xhp8kin0	34	12	"	"	``
cord-030594-xhp8kin0	34	13	negative	negative	JJ
cord-030594-xhp8kin0	34	14	"	"	''
cord-030594-xhp8kin0	34	15	acute	acute	JJ
cord-030594-xhp8kin0	34	16	-	-	HYPH
cord-030594-xhp8kin0	34	17	phase	phase	NN
cord-030594-xhp8kin0	34	18	proteins	protein	NNS
cord-030594-xhp8kin0	34	19	in	in	IN
cord-030594-xhp8kin0	34	20	response	response	NN
cord-030594-xhp8kin0	34	21	to	to	IN
cord-030594-xhp8kin0	34	22	inflammation	inflammation	NN
cord-030594-xhp8kin0	34	23	,	,	,
cord-030594-xhp8kin0	34	24	is	be	VBZ
cord-030594-xhp8kin0	34	25	reduced	reduce	VBN
cord-030594-xhp8kin0	34	26	even	even	RB
cord-030594-xhp8kin0	34	27	in	in	IN
cord-030594-xhp8kin0	34	28	the	the	DT
cord-030594-xhp8kin0	34	29	acute	acute	JJ
cord-030594-xhp8kin0	34	30	phase	phase	NN
cord-030594-xhp8kin0	34	31	of	of	IN
cord-030594-xhp8kin0	34	32	severe	severe	JJ
cord-030594-xhp8kin0	34	33	COVID-19	covid-19	JJ
cord-030594-xhp8kin0	34	34	pneumonia	pneumonia	NN
cord-030594-xhp8kin0	34	35	.	.	.
cord-030594-xhp8kin0	35	1	Following	follow	VBG
cord-030594-xhp8kin0	35	2	the	the	DT
cord-030594-xhp8kin0	35	3	changes	change	NNS
cord-030594-xhp8kin0	35	4	in	in	IN
cord-030594-xhp8kin0	35	5	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	35	6	over	over	IN
cord-030594-xhp8kin0	35	7	time	time	NN
cord-030594-xhp8kin0	35	8	,	,	,
cord-030594-xhp8kin0	35	9	we	-PRON-	PRP
cord-030594-xhp8kin0	35	10	found	find	VBD
cord-030594-xhp8kin0	35	11	that	that	IN
cord-030594-xhp8kin0	35	12	it	-PRON-	PRP
cord-030594-xhp8kin0	35	13	decreased	decrease	VBD
cord-030594-xhp8kin0	35	14	with	with	IN
cord-030594-xhp8kin0	35	15	deterioration	deterioration	NN
cord-030594-xhp8kin0	35	16	of	of	IN
cord-030594-xhp8kin0	35	17	the	the	DT
cord-030594-xhp8kin0	35	18	condition	condition	NN
cord-030594-xhp8kin0	35	19	and	and	CC
cord-030594-xhp8kin0	35	20	increased	increase	VBD
cord-030594-xhp8kin0	35	21	with	with	IN
cord-030594-xhp8kin0	35	22	improvement	improvement	NN
cord-030594-xhp8kin0	35	23	.	.	.
cord-030594-xhp8kin0	36	1	Cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	36	2	level	level	NN
cord-030594-xhp8kin0	36	3	on	on	IN
cord-030594-xhp8kin0	36	4	admission	admission	NN
cord-030594-xhp8kin0	36	5	is	be	VBZ
cord-030594-xhp8kin0	36	6	suggested	suggest	VBN
cord-030594-xhp8kin0	36	7	to	to	TO
cord-030594-xhp8kin0	36	8	be	be	VB
cord-030594-xhp8kin0	36	9	an	an	DT
cord-030594-xhp8kin0	36	10	independent	independent	JJ
cord-030594-xhp8kin0	36	11	predictor	predictor	NN
cord-030594-xhp8kin0	36	12	of	of	IN
cord-030594-xhp8kin0	36	13	severity	severity	NN
cord-030594-xhp8kin0	36	14	and	and	CC
cord-030594-xhp8kin0	36	15	mortality	mortality	NN
cord-030594-xhp8kin0	36	16	for	for	IN
cord-030594-xhp8kin0	36	17	COVID-19	COVID-19	NNP
cord-030594-xhp8kin0	36	18	pneumonia	pneumonia	NN
cord-030594-xhp8kin0	36	19	.	.	.
cord-030594-xhp8kin0	37	1	Cholinesterase	Cholinesterase	NNP
cord-030594-xhp8kin0	37	2	levels	level	NNS
cord-030594-xhp8kin0	37	3	on	on	IN
cord-030594-xhp8kin0	37	4	admission	admission	NN
cord-030594-xhp8kin0	37	5	were	be	VBD
cord-030594-xhp8kin0	37	6	significantly	significantly	RB
cord-030594-xhp8kin0	37	7	lower	low	JJR
cord-030594-xhp8kin0	37	8	in	in	IN
cord-030594-xhp8kin0	37	9	the	the	DT
cord-030594-xhp8kin0	37	10	severe	severe	JJ
cord-030594-xhp8kin0	37	11	group	group	NN
cord-030594-xhp8kin0	37	12	than	than	IN
cord-030594-xhp8kin0	37	13	in	in	IN
cord-030594-xhp8kin0	37	14	the	the	DT
cord-030594-xhp8kin0	37	15	mild	mild	NN
cord-030594-xhp8kin0	37	16	-	-	HYPH
cord-030594-xhp8kin0	37	17	to	to	IN
cord-030594-xhp8kin0	37	18	-	-	HYPH
cord-030594-xhp8kin0	37	19	moderate	moderate	JJ
cord-030594-xhp8kin0	37	20	group	group	NN
cord-030594-xhp8kin0	37	21	,	,	,
cord-030594-xhp8kin0	37	22	and	and	CC
cord-030594-xhp8kin0	37	23	they	-PRON-	PRP
cord-030594-xhp8kin0	37	24	were	be	VBD
cord-030594-xhp8kin0	37	25	also	also	RB
cord-030594-xhp8kin0	37	26	significantly	significantly	RB
cord-030594-xhp8kin0	37	27	lower	low	JJR
cord-030594-xhp8kin0	37	28	in	in	IN
cord-030594-xhp8kin0	37	29	the	the	DT
cord-030594-xhp8kin0	37	30	death	death	NN
cord-030594-xhp8kin0	37	31	group	group	NN
cord-030594-xhp8kin0	37	32	than	than	IN
cord-030594-xhp8kin0	37	33	in	in	IN
cord-030594-xhp8kin0	37	34	the	the	DT
cord-030594-xhp8kin0	37	35	survival	survival	NN
cord-030594-xhp8kin0	37	36	group	group	NN
cord-030594-xhp8kin0	37	37	.	.	.
cord-030594-xhp8kin0	38	1	Cholinesterase	Cholinesterase	NNP
cord-030594-xhp8kin0	38	2	was	be	VBD
cord-030594-xhp8kin0	38	3	comparable	comparable	JJ
cord-030594-xhp8kin0	38	4	to	to	IN
cord-030594-xhp8kin0	38	5	other	other	JJ
cord-030594-xhp8kin0	38	6	markers	marker	NNS
cord-030594-xhp8kin0	38	7	,	,	,
cord-030594-xhp8kin0	38	8	such	such	JJ
cord-030594-xhp8kin0	38	9	as	as	IN
cord-030594-xhp8kin0	38	10	C	C	NNP
cord-030594-xhp8kin0	38	11	-	-	HYPH
cord-030594-xhp8kin0	38	12	reactive	reactive	JJ
cord-030594-xhp8kin0	38	13	protein	protein	NN
cord-030594-xhp8kin0	38	14	,	,	,
cord-030594-xhp8kin0	38	15	PaO	pao	JJ
cord-030594-xhp8kin0	38	16	2	2	CD
cord-030594-xhp8kin0	38	17	/FiO	/fio	SYM
cord-030594-xhp8kin0	38	18	2	2	CD
cord-030594-xhp8kin0	38	19	ratio	ratio	NN
cord-030594-xhp8kin0	38	20	,	,	,
cord-030594-xhp8kin0	38	21	albumin	albumin	NN
cord-030594-xhp8kin0	38	22	,	,	,
cord-030594-xhp8kin0	38	23	・Funding	・funde	VBG
cord-030594-xhp8kin0	38	24	This	this	DT
cord-030594-xhp8kin0	38	25	research	research	NN
cord-030594-xhp8kin0	38	26	did	do	VBD
cord-030594-xhp8kin0	38	27	not	not	RB
cord-030594-xhp8kin0	38	28	receive	receive	VB
cord-030594-xhp8kin0	38	29	any	any	DT
cord-030594-xhp8kin0	38	30	specific	specific	JJ
cord-030594-xhp8kin0	38	31	grant	grant	NN
cord-030594-xhp8kin0	38	32	from	from	IN
cord-030594-xhp8kin0	38	33	funding	fund	VBG
cord-030594-xhp8kin0	38	34	agencies	agency	NNS
cord-030594-xhp8kin0	38	35	in	in	IN
cord-030594-xhp8kin0	38	36	the	the	DT
cord-030594-xhp8kin0	38	37	public	public	NN
cord-030594-xhp8kin0	38	38	,	,	,
cord-030594-xhp8kin0	38	39	commercial	commercial	JJ
cord-030594-xhp8kin0	38	40	,	,	,
cord-030594-xhp8kin0	38	41	or	or	CC
cord-030594-xhp8kin0	38	42	not	not	RB
cord-030594-xhp8kin0	38	43	-	-	HYPH
cord-030594-xhp8kin0	38	44	for	for	IN
cord-030594-xhp8kin0	38	45	-	-	HYPH
cord-030594-xhp8kin0	38	46	profit	profit	NN
cord-030594-xhp8kin0	38	47	sectors	sector	NNS
cord-030594-xhp8kin0	38	48	.	.	.
cord-030594-xhp8kin0	38	49	 	 	_SP
cord-030594-xhp8kin0	39	1	Markers	marker	NNS
cord-030594-xhp8kin0	39	2	of	of	IN
cord-030594-xhp8kin0	39	3	liver	liver	NN
cord-030594-xhp8kin0	39	4	injury	injury	NN
cord-030594-xhp8kin0	39	5	and	and	CC
cord-030594-xhp8kin0	39	6	clinical	clinical	JJ
cord-030594-xhp8kin0	39	7	outcomes	outcome	NNS
cord-030594-xhp8kin0	39	8	in	in	IN
cord-030594-xhp8kin0	39	9	COVID-19	covid-19	CD
cord-030594-xhp8kin0	39	10	patients	patient	NNS
cord-030594-xhp8kin0	39	11	:	:	:
cord-030594-xhp8kin0	40	1	A	a	DT
cord-030594-xhp8kin0	40	2	systematic	systematic	JJ
cord-030594-xhp8kin0	40	3	review	review	NN
cord-030594-xhp8kin0	40	4	and	and	CC
cord-030594-xhp8kin0	40	5	meta	meta	NN
cord-030594-xhp8kin0	40	6	-	-	HYPH
cord-030594-xhp8kin0	40	7	analysis	analysis	NN
cord-030594-xhp8kin0	40	8	Butyrylcholinesterase	Butyrylcholinesterase	NNP
cord-030594-xhp8kin0	40	9	as	as	IN
cord-030594-xhp8kin0	40	10	a	a	DT
cord-030594-xhp8kin0	40	11	prognostic	prognostic	JJ
cord-030594-xhp8kin0	40	12	marker	marker	NN
cord-030594-xhp8kin0	40	13	:	:	:
cord-030594-xhp8kin0	40	14	a	a	DT
cord-030594-xhp8kin0	40	15	review	review	NN
cord-030594-xhp8kin0	40	16	of	of	IN
cord-030594-xhp8kin0	40	17	the	the	DT
cord-030594-xhp8kin0	40	18	literature	literature	NN
cord-030594-xhp8kin0	41	1	A	a	DT
cord-030594-xhp8kin0	41	2	sustained	sustained	JJ
cord-030594-xhp8kin0	41	3	reduction	reduction	NN
cord-030594-xhp8kin0	41	4	in	in	IN
cord-030594-xhp8kin0	41	5	serum	serum	NN
cord-030594-xhp8kin0	41	6	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	41	7	enzyme	enzyme	NN
cord-030594-xhp8kin0	41	8	activity	activity	NN
cord-030594-xhp8kin0	41	9	predicts	predict	VBZ
cord-030594-xhp8kin0	41	10	patient	patient	JJ
cord-030594-xhp8kin0	41	11	outcome	outcome	NN
cord-030594-xhp8kin0	41	12	following	follow	VBG
cord-030594-xhp8kin0	41	13	sepsis	sepsis	NN
cord-030594-xhp8kin0	41	14	Value	value	NN
cord-030594-xhp8kin0	41	15	of	of	IN
cord-030594-xhp8kin0	41	16	serum	serum	NN
cord-030594-xhp8kin0	41	17	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	41	18	in	in	IN
cord-030594-xhp8kin0	41	19	the	the	DT
cord-030594-xhp8kin0	41	20	prognosis	prognosis	NN
cord-030594-xhp8kin0	41	21	of	of	IN
cord-030594-xhp8kin0	41	22	septic	septic	JJ
cord-030594-xhp8kin0	41	23	shock	shock	NN
cord-030594-xhp8kin0	41	24	Serum	serum	NN
cord-030594-xhp8kin0	41	25	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	41	26	is	be	VBZ
cord-030594-xhp8kin0	41	27	an	an	DT
cord-030594-xhp8kin0	41	28	excellent	excellent	JJ
cord-030594-xhp8kin0	41	29	biomarker	biomarker	NN
cord-030594-xhp8kin0	41	30	of	of	IN
cord-030594-xhp8kin0	41	31	cirrhosis	cirrhosis	NN
cord-030594-xhp8kin0	41	32	Acetylcholinesterase	acetylcholinesterase	NN
cord-030594-xhp8kin0	41	33	and	and	CC
cord-030594-xhp8kin0	41	34	butyrylcholinesterase	butyrylcholinesterase	NN
cord-030594-xhp8kin0	41	35	as	as	IN
cord-030594-xhp8kin0	41	36	possible	possible	JJ
cord-030594-xhp8kin0	41	37	markers	marker	NNS
cord-030594-xhp8kin0	41	38	of	of	IN
cord-030594-xhp8kin0	41	39	low	low	JJ
cord-030594-xhp8kin0	41	40	-	-	HYPH
cord-030594-xhp8kin0	41	41	grade	grade	NN
cord-030594-xhp8kin0	41	42	systemic	systemic	JJ
cord-030594-xhp8kin0	41	43	inflammation	inflammation	NN
cord-030594-xhp8kin0	41	44	Value	value	NN
cord-030594-xhp8kin0	41	45	of	of	IN
cord-030594-xhp8kin0	41	46	serum	serum	NN
cord-030594-xhp8kin0	41	47	cholinesterase	cholinesterase	NN
cord-030594-xhp8kin0	41	48	activity	activity	NN
cord-030594-xhp8kin0	41	49	in	in	IN
cord-030594-xhp8kin0	41	50	the	the	DT
cord-030594-xhp8kin0	41	51	diagnosis	diagnosis	NN
cord-030594-xhp8kin0	41	52	of	of	IN
cord-030594-xhp8kin0	41	53	septic	septic	JJ
cord-030594-xhp8kin0	41	54	shock	shock	NN
cord-030594-xhp8kin0	41	55	due	due	IN
cord-030594-xhp8kin0	41	56	to	to	IN
cord-030594-xhp8kin0	41	57	bacterial	bacterial	JJ
cord-030594-xhp8kin0	41	58	infections	infection	NNS
cord-030594-xhp8kin0	41	59	Advances	advance	NNS
cord-030594-xhp8kin0	41	60	in	in	IN
cord-030594-xhp8kin0	41	61	understanding	understanding	NN
cord-030594-xhp8kin0	41	62	and	and	CC
cord-030594-xhp8kin0	41	63	assessing	assess	VBG
cord-030594-xhp8kin0	41	64	malnutrition	malnutrition	NN
cord-030594-xhp8kin0	41	65	Protein	protein	NN
cord-030594-xhp8kin0	41	66	-	-	HYPH
cord-030594-xhp8kin0	41	67	energy	energy	NN
cord-030594-xhp8kin0	41	68	malnutrition	malnutrition	NN
cord-030594-xhp8kin0	41	69	:	:	:
cord-030594-xhp8kin0	41	70	its	-PRON-	PRP$
cord-030594-xhp8kin0	41	71	effects	effect	NNS
cord-030594-xhp8kin0	41	72	on	on	IN
cord-030594-xhp8kin0	41	73	4	4	CD
cord-030594-xhp8kin0	41	74	metabolic	metabolic	JJ
cord-030594-xhp8kin0	41	75	parameters	parameter	NNS
cord-030594-xhp8kin0	41	76	Plasma	plasma	NN
cord-030594-xhp8kin0	41	77	esterases	esterase	NNS
cord-030594-xhp8kin0	41	78	and	and	CC
cord-030594-xhp8kin0	41	79	inflammation	inflammation	NN
cord-030594-xhp8kin0	41	80	in	in	IN
cord-030594-xhp8kin0	41	81	ageing	age	VBG
cord-030594-xhp8kin0	41	82	and	and	CC
cord-030594-xhp8kin0	41	83	frailty	frailty	NN
cord-030594-xhp8kin0	41	84	Median	median	JJ
cord-030594-xhp8kin0	41	85	laboratory	laboratory	NN
cord-030594-xhp8kin0	41	86	values	value	NNS
cord-030594-xhp8kin0	41	87	(	(	-LRB-
cord-030594-xhp8kin0	41	88	IQR	iqr	NN
cord-030594-xhp8kin0	41	89	)	)	-RRB-
cord-030594-xhp8kin0	41	90	ChE	ChE	NNP
cord-030594-xhp8kin0	42	1	(	(	-LRB-
cord-030594-xhp8kin0	42	2	U	U	NNP
cord-030594-xhp8kin0	42	3	/	/	SYM
cord-030594-xhp8kin0	42	4	L	l	NN
cord-030594-xhp8kin0	42	5	)	)	-RRB-
cord-030594-xhp8kin0	43	1	*	*	NFP
cord-030594-xhp8kin0	43	2	The	the	DT
cord-030594-xhp8kin0	43	3	mild	mild	JJ
cord-030594-xhp8kin0	43	4	-	-	HYPH
cord-030594-xhp8kin0	43	5	to	to	IN
cord-030594-xhp8kin0	43	6	-	-	HYPH
cord-030594-xhp8kin0	43	7	moderate	moderate	JJ
cord-030594-xhp8kin0	43	8	group	group	NN
cord-030594-xhp8kin0	43	9	was	be	VBD
cord-030594-xhp8kin0	43	10	defined	define	VBN
cord-030594-xhp8kin0	43	11	based	base	VBN
cord-030594-xhp8kin0	43	12	on	on	IN
cord-030594-xhp8kin0	43	13	the	the	DT
cord-030594-xhp8kin0	43	14	need	need	NN
cord-030594-xhp8kin0	43	15	for	for	IN
cord-030594-xhp8kin0	43	16	oxygen	oxygen	NN
cord-030594-xhp8kin0	43	17	inhalation	inhalation	NN
cord-030594-xhp8kin0	43	18	or	or	CC
cord-030594-xhp8kin0	43	19	no	no	DT
cord-030594-xhp8kin0	43	20	oxygen	oxygen	NN
cord-030594-xhp8kin0	43	21	inhalation	inhalation	NN
cord-030594-xhp8kin0	44	1	The	the	DT
cord-030594-xhp8kin0	44	2	severe	severe	JJ
cord-030594-xhp8kin0	44	3	group	group	NN
cord-030594-xhp8kin0	44	4	was	be	VBD
cord-030594-xhp8kin0	44	5	defined	define	VBN
cord-030594-xhp8kin0	44	6	as	as	IN
cord-030594-xhp8kin0	44	7	having	have	VBG
cord-030594-xhp8kin0	44	8	a	a	DT
cord-030594-xhp8kin0	44	9	respiratory	respiratory	JJ
cord-030594-xhp8kin0	44	10	condition	condition	NN
cord-030594-xhp8kin0	44	11	requiring	require	VBG
cord-030594-xhp8kin0	44	12	ventilator	ventilator	NN
cord-030594-xhp8kin0	44	13	management	management	NN
cord-030594-xhp8kin0	44	14	(	(	-LRB-
cord-030594-xhp8kin0	44	15	PaO2	PaO2	NNS
cord-030594-xhp8kin0	44	16	/	/	SYM
cord-030594-xhp8kin0	44	17	FiO2	FiO2	NNP
cord-030594-xhp8kin0	44	18	ratio	ratio	NN
cord-030594-xhp8kin0	45	1	<	<	XX
cord-030594-xhp8kin0	45	2	200	200	CD
cord-030594-xhp8kin0	45	3	mmHg	mmHg	NNS
cord-030594-xhp8kin0	45	4	to	to	IN
cord-030594-xhp8kin0	45	5	respiratory	respiratory	JJ
cord-030594-xhp8kin0	45	6	rate	rate	NN
cord-030594-xhp8kin0	45	7	>	>	XX
cord-030594-xhp8kin0	45	8	30	30	CD
cord-030594-xhp8kin0	45	9	/min	/min	NFP
cord-030594-xhp8kin0	45	10	)	)	-RRB-